Company Monitoring Page for Novartis

latest headlines for company on cafepharma

FDA Approves Crizanlizumab: Here Is A New Drug For Sickle Cell Disease
Forbes
Sun, 11/17/19 - 08:42 pm
Tags:
Novartis, Adakveo, FDA, crizanlizumab, sickle cell disease
AHA: Novartis hoping for second go at broader use with 'profound' Entresto subdata
Fierce Pharma
Sun, 11/17/19 - 08:38 pm
Tags:
Novartis, AHA, Entresto
Novartis sickle-cell drug wins FDA approval
Biopharma Dive
Fri, 11/15/19 - 11:57 pm
Tags:
FDA, Novartis, Adakveo, sickle cell disease
Five drugs, including two Novartis therapies, win EMA endorsement
Endpoints
Fri, 11/15/19 - 12:22 pm
Tags:
EMA, Europe, Novartis, Mayzent, Isturisa, Roche, Polivy, Jazz Pharma, Sunosi, Rigel Pharma, Tavlesse
Roche sets sights on Novartis, Biogen as SMA trial hits target
Yahoo/Reuters
Mon, 11/11/19 - 10:49 am
Tags:
Roche, SMA, risdiplam, Biogen, Novartis, clinical trials
Novartis' Generics Unit to Buy Aspen's Japanese Operations
Yahoo/Zacks.com
Mon, 11/11/19 - 10:47 am
Tags:
Novartis, generics, Sandoz, M&A, Japan, Aspen Pharmacare, Aspen Global
It took a 3-year struggle, but Novartis finally gets a green light on their copycat to Amgen's big blockbuster
Endpoints
Tue, 11/5/19 - 10:23 am
Tags:
Novartis, FDA, Amgen, Neulasta, biosimilars, Ziextenzo, cancer
Novartis says delayed telling FDA of Zolgensma concern due to "mistake"
Yahoo/Reuters
Sat, 11/2/19 - 07:51 pm
Tags:
Novartis, FDA, Zolgensma, SMA
Novartis’ Cosentyx Narrowly Misses Beating Out AbbVie’s Humira in Arthritis Trial
BioSpace
Fri, 11/1/19 - 11:50 am
Tags:
Novartis, Cosentyx, AbbVie, Humira, clinical trial, psoriatic arthritis
Novartis Admits to ‘Mistake’ After Partial Clinical Hold Placed on Zolgensma Trial
RAPS.org
Thu, 10/31/19 - 11:54 pm
Tags:
Novartis, Zolgensma, clinical trials, SMA, FDA
Oooooh, That’s Scary! Welcome to the Dark Side of Biopharma
BioSpace
Thu, 10/31/19 - 10:37 am
Tags:
CRISPR, drug pricing, Novartis, Zolgensma, bioterrorism, Elizabeth Holmes, Martin Shkreli
Novartis’ Zolgensma gene therapy study halted by FDA on animal safety concerns
Stat
Wed, 10/30/19 - 10:32 am
Tags:
Novartis, Zolgensma, FDA, gene therapy, clinical trials, SMA
Trials of Novartis' Dupixent rival bet scrapped by MorphoSys, Galapagos
Fierce Biotech
Tue, 10/29/19 - 09:57 am
Tags:
MorphoSys, Galapagos, Novartis, MOR106, atopic dermatitis, Dupixent, Sanofi
Novartis sends second wagon after KRAS gold rush
Endpoints
Fri, 10/25/19 - 10:46 am
Tags:
Novartis, KRAS, drug discovery
Novartis bets $80M on Pliant's preclinical NASH prospect
Fierce Biotech
Wed, 10/23/19 - 10:39 pm
Tags:
Novartis, NASH, Pliant Therapeutics, PLN-1474
Novartis downplays late-stage asthma drug failures
BioSpace
Wed, 10/23/19 - 10:31 pm
Tags:
Novartis, asthma, clinical tirals, fevipiprant
Novartis Earnings Top; Swiss Drug Giant Edges Lower
Investors Business Daily
Tue, 10/22/19 - 10:48 am
Tags:
Novartis, earnings
Zolgensma hits the ground running, says Novartis
Pharmaforum
Tue, 10/22/19 - 10:33 am
Tags:
Novartis, Zolgensma, AveXis, SMA, payers
Novartis' asthma drug fails in phase 3, raising doubts about Gossamer's prospects
Fierce Biotech
Tue, 10/22/19 - 10:28 am
Tags:
Novartis, clinical trials, fevipiprant, asthma, Gossamer Bio
Upcoming events – Novartis’s asthma Zeal and Alnylam's lumasiran test
EP Vantage
Sat, 10/19/19 - 01:36 pm
Tags:
Novartis, fevipiprant, severe asthma, Alnylam, lumasiran, Primary Hyperoxaluria

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.